Len Blavatnik Reports a $15 Million DAWN Buy

From the Desk of Steve Strazza and Alfonso Depablos

The most significant transaction on today’s list comes in a Form 4 filing by Len Blavatnik.

Blavatnik reported a purchase of $14.9 million in Day One Biopharmaceuticals $DAWN.

Here’s The Hot Corner, with data through October 20, 2023:

Point72 Asset Management filed a 13G for Semtech Corporation $SMTC revealing an initial stake of 7.30%.

In another Form 4, Ares Management revealed a purchase of 150,000 shares in Frontier Communications Parent $FYBR.

Stay tuned. We’ll be back on Tuesday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Source link

Be the first to comment

Leave a Reply

Your email address will not be published.